Forte Biosciences Inc (FBRX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$76.990.00%
Close 2026-08-28 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · FBRX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||
| Revenues | — | — | — | — | — | — | — | 0.0 | 18.0 | — |
| Operating Expenses & Income | ||||||||||
| R&D Expenses | — | — | — | — | — | — | — | 45.3 | 51.1 | 29.1 |
| Operating Income | (90.0) | (70.7) | (36.6) | (32.5) | (13.9) | (21.5) | (46.3) | (4.1) | (45.9) | (37.6) |
| Earnings from Continuing Operations | ||||||||||
| Other Non-Operating Income / Expenses | — | 2.3 | — | — | — | — | — | — | — | (1.3) |
| EBT, Incl. Unusual Items | — | (68.3) | (35.5) | (31.5) | — | — | — | (63.5) | (47.3) | — |
| Income Tax Expense | — | 1.0 | — | — | — | — | — | 0.0 | 1.7 | — |
| Net Income | ||||||||||
| Net Income | (87.9) | (69.4) | (35.5) | (31.5) | (13.9) | (21.7) | (46.5) | (4.1) | (49.0) | (38.9) |
| Per Share | ||||||||||
| Basic EPS | — | (4.71) | (12.17) | (24.92) | (0.80) | (1.55) | — | — | — | — |
| Diluted EPS | — | (4.71) | (12.17) | (24.92) | (0.80) | (1.55) | — | — | — | — |
| Basic Weighted Avg Shares | — | — | — | — | 17.4 | 14.0 | — | — | — | — |
| Diluted Weighted Avg Shares | — | — | — | — | 17.4 | 14.0 | — | — | — | — |
| Supplemental | ||||||||||
| EBIT | (90.0) | (70.7) | (36.6) | (32.5) | (13.9) | (21.5) | (46.3) | (4.1) | (45.9) | (37.6) |
| Effective Tax Rate | — | — | — | — | — | — | — | -0.0% | -3.6% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.